Evaluation of 5-hydroxy-1,4-naphthoquinone-cobalt(III) complexes for hypoxia-activated drug delivery-Reference-Cited by-同舟云学术

Evaluation of 5-hydroxy-1,4-naphthoquinone-cobalt(III) complexes for hypoxia-activated drug delivery

Published:2019-10 Issue: Volume:199 Page:110756
ISSN:0162-0134
Container-title:Journal of Inorganic Biochemistry
language:en
Short-container-title:Journal of Inorganic Biochemistry

Author:

de Mello Marcos Vinícius Palmeira,Cebrián-Torrejón Gerardo,Pereira Jonas Ramos,dos Santos Moreira Caroline,Gomes Carinne Borges de Souza Moraes Rego,da Rocha David Rodrigues,de Souza Fagundes Elaine Maria,Ferreira Glaucio Braga,Lanznaster Mauricio

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Biochemistry

Reference64 articles.

1. Targeting hypoxia in cancer therapy

2. Hypoxia-activated prodrugs in cancer therapy: progress to the clinic

3. Redox activation of metal-based prodrugs as a strategy for drug delivery

4. Exploiting tumor hypoxia through bioreductive release of diffusible cytotoxins: The cobalt(III)-nitrogen mustard complex SN 24771

5. Bioreductive activation and drug chaperoning in cobalt pharmaceuticals

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Development of Transition Metal Complexes as Chemotherapeutic Hypoxia Activated Prodrug (HAP);ChemMedChem;2024-06-03

2. Unlocking the potential of 1,4-naphthoquinones: A comprehensive review of their anticancer properties;European Journal of Medicinal Chemistry;2024-03

3. Exploring the potential of ruthenium(ii)–phosphine–mercapto complexes as new anticancer agents;Dalton Transactions;2024

4. Cobalt(III)-py2en systems as potential carriers of β-ketoester-based ligands;Journal of Inorganic Biochemistry;2023-11

5. Investigation of mesalazine-cobalt(III) complexes for hypoxia-activated prodrug development;Inorganic Chemistry Communications;2023-07